Topics

PARP Inhibitors Slow Spread of Inherited Breast Cancer Caused by BRCA Mutations.

09:27 EST 13 Feb 2020 | Cancer Connect

The PARP inhibitor medications Lynparza and Veliparib improve outcomes in BRCA mutataed breast cancer

Original Article: PARP Inhibitors Slow Spread of Inherited Breast Cancer Caused by BRCA Mutations.

NEXT ARTICLE

More From BioPortfolio on "PARP Inhibitors Slow Spread of Inherited Breast Cancer Caused by BRCA Mutations."

Quick Search

Relevant Topic

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...